Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Vascular function in adults with cyanotic congenital heart disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Carotid atherosclerosis markers and adverse cardiovascular events

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Clinical validation of three-dimensional ultrasound for abdominal aortic aneurysm

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Carotid Intima-Media Thickness Versus Carotid Plaque Burden for Predicting Cardiovascular Risk

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Alfred Callahan
  • Pierre Amarenco
  • Larry B Goldstein
  • Henrik Sillesen
  • Mike Messig
  • Gregory P Samsa
  • Irfan Altafullah
  • Lucy Y Ledbetter
  • Mary J MacLeod
  • Russell Scott
  • Michael Hennerici
  • Justin A Zivin
  • K Michael A Welch
  • SPARCL Investigators
Vis graf over relationer
To perform a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial, which tested the effect of treatment with atorvastatin in reducing stroke in subjects with a recent stroke or transient ischemic attack, to explore the effects of treatment in subjects with type 2 diabetes mellitus or metabolic syndrome (MetS).
OriginalsprogEngelsk
TidsskriftArchives of Neurology
Vol/bind68
Udgave nummer10
Sider (fra-til)1245-51
Antal sider7
ISSN0003-9942
DOI
StatusUdgivet - 2011

ID: 33198376